Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-14Clinical Trial Update: Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy de-escalation in early-stage HER2-positive breast cancer has been withdrawn from the study registry.
-
CLINICAL_TRIALS withdrawal · 2025-10-14Clinical Trial Update: What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care
A clinical trial evaluating real-time result delivery during screening mammography for breast cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-26Clinical Trial Update: Online Patient Navigation Program for Patients With Breast Cancer [NA]
This clinical trial evaluating an online patient navigation program for breast cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-26Clinical Trial Update: Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis. [NA]
Clinical trial investigating exosome analyses in cerebrospinal fluid for breast cancer patients with suspected leptomeningeal metastasis has…
-
CLINICAL_TRIALS withdrawal · 2025-09-17Clinical Trial Update: Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema [NA]
A clinical trial evaluating indocyanine green fluoroscopy and SPY angiography to assess lymphatic structures in breast cancer patients at ri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-09-16Clinical Trial Update: Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy [NA]
A feasibility study evaluating Ablathermy focused ultrasound for breast tumors prior to mastectomy has been withdrawn from ClinicalTrials.go…
-
CLINICAL_TRIALS withdrawal · 2025-09-11Clinical Trial Update: Psychological and Social Factors and Risk Chronic Pain After Surgery in Women With Breast Cancer
A clinical trial examining psychosocial factors and the risk of chronic postoperative pain after breast cancer surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer.
The clinical trial evaluating a socio-aesthetic intervention to improve body image and quality of life in women with breast cancer has been …
-
CLINICAL_TRIALS withdrawal · 2025-08-17Clinical Trial Update: Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer [Phase 2]
Phase 2 trial of talazoparib monotherapy for PALB2 mutation-associated advanced breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of AB-201 for HER2-positive solid tumors has been withdrawn, with the study status updated to withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-08Clinical Trial Update: CharactHer. ICORG 12-09, V3
The CharactHer ICORG 12-09 trial investigating HER2-positive and stage II-IV breast cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-07-03Clinical Trial Update: Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer [Phase 1]
A National Cancer Institute-sponsored Phase 1 trial evaluating adding ASTX660 (tolinapant) to eribulin for advanced triple-negative breast c…
-
CLINICAL_TRIALS withdrawal · 2025-07-01Clinical Trial Update: A Study to Investigate LYL797 in Adults With Solid Tumors [Phase 1]
Lyell Immunopharma's Phase 1 study of LYL797 in adults with solid tumors has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-06-26Clinical Trial Update: A Trial Assessing Feasibility of Allostatic Load Biomarkers and CVD Risk Among Black Breast Cancer Survivors [NA]
This withdrawn clinical trial evaluated the feasibility of using allostatic load biomarkers to assess cardiovascular risk among Black breast…
-
CLINICAL_TRIALS withdrawal · 2025-06-25Clinical Trial Update: Regional Anesthesia for Breast Surgery [NA]
A clinical trial evaluating regional anesthesia for breast surgery in breast cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-04Clinical Trial Update: Defining Musical Toxicity and Its Effect on Patient Well-being
A Mayo Clinic-sponsored clinical trial titled 'Defining Musical Toxicity and Its Effect on Patient Well-being' has been withdrawn from the r…
-
CLINICAL_TRIALS withdrawal · 2025-05-21Clinical Trial Update: A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer
A clinical trial evaluating contrast-enhanced mammography in people with breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-18Clinical Trial Update: An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6 [NA]
A clinical trial investigating imaging in estrogen receptor-negative breast cancer by targeting αvβ6 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-18Clinical Trial Update: A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer [EARLY_Phase 1]
A Phase 1 study evaluating 18F-FDHT PET/MRI scans in women with breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial of an investigational drug in combination with two chemotherapy drugs for locally recurrent or metastatic breast …
-
CLINICAL_TRIALS withdrawal · 2025-04-30Clinical Trial Update: Comparing Breast Magnetic Resonance Imaging (MRI) and Contrast-enhanced Mammography (CEM) [NA]
A clinical trial comparing breast magnetic resonance imaging (MRI) with contrast-enhanced mammography (CEM) for breast cancer has been withd…
-
CLINICAL_TRIALS withdrawal · 2025-04-29Clinical Trial Update: Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer [Phase 1, Phase 2]
A clinical trial evaluating a breast cancer vaccine in combination with pembrolizumab for persistent, recurrent, or metastatic breast cancer…
-
CLINICAL_TRIALS withdrawal · 2025-04-22Clinical Trial Update: A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports the withdrawal of a rollover protocol studying elacestrant in combination with onapristone for ER-positiv…
-
CLINICAL_TRIALS withdrawal · 2025-04-09Clinical Trial Update: Study of OB-002 in Patients With Refractory Metastatic Cancer [Phase 1]
Phase 1 study of OB-002 in various metastatic cancers has been withdrawn from clinical trials.
-
CLINICAL_TRIALS withdrawal · 2025-03-19Clinical Trial Update: A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer's post-marketing surveillance study of Zirabev to assess safety and effectiveness in domestic cancer patients has been withdrawn.